Dow Down0.92% Nasdaq Down0.83%

Bio-Reference Laboratories Inc. (BRLI)

28.83 0.42(1.44%) Oct 22, 4:00PM EDT
ProfileGet Profile for:
Bio-Reference Laboratories Inc.
481 Edward H. Ross Drive
Elmwood Park, NJ 07407
United States - Map
Phone: 201-791-2600

Index Membership:N/A
Industry:Medical Laboratories & Research
Full Time Employees:3,338

Business Summary 

Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area. The company offers chemical diagnostic tests, such as blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology (including drug screening), pap smears, tissue pathology (biopsies), and other tissue analysis, as well as performs cancer cytogenetic testing. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional health care services. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems; and a Web-based connectivity portal solution for laboratories and physicians. Bio-Reference Laboratories, Inc. provides its services directly to physicians, geneticists, hospitals, clinics, and correctional and other health facilities. The company was founded in 1981 and is headquartered in Elmwood Park, New Jersey.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Bio-Reference Laboratories Inc.

Corporate Governance 
Bio-Reference Laboratories Inc.’s ISS Governance QuickScore as of Oct 1, 2014 is 8. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 7; Compensation: 3.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Dr. Marc D. Grodman M.D., 62
Founder, Chairman, Chief Exec. Officer, Pres and Managing Director
Mr. Sam Singer , 70
Chief Financial Officer, Chief Accounting Officer, Sr. VP and Director
Mr. Howard Dubinett , 62
Chief Operating Officer, Exec. VP and Director
Dr. John Roglieri M.D., 75
Director, Chairman of Compensation Committee, Chairman of Nominating Committee and Member of Audit Committee
Ms. Wendy Chung ,
Chief Scientific Officer
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders